[EXTRAPYRAMIDAL SYMPTOMS DUE TO THE USE OF PSYCHOPHARMACA].
D002746:Chlorpromazine / Q000633:toxicity*; D002749:Chlorprothixene; D005116:Extrapyramidal Tracts; D005476:Fluphenazine; D007099:Imipramine; D008728:Methotrimeprazine; D008996:Monoamine Oxidase Inhibitors; D020734:Parkinsonian Disorders; D010640:Phenothiazines; D011346:Prochlorperazine; D011395:Promazine; D011600:Psychopharmacology; D011926:Rauwolfia; D013566:Sympathomimetics; D013881:Thioridazine; D014116:Toxicology; D014149:Tranquilizing Agents; D014268:Trifluoperazine
D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D013566:Sympathomimetics; D014149:Tranquilizing Agents; D014268:Trifluoperazine; C100190:mepazine; D008728:Methotrimeprazine; D002749:Chlorprothixene; C031637:phenothiazine; D013881:Thioridazine; D011395:Promazine; D007099:Imipramine; D005476:Fluphenazine; D002746:Chlorpromazine; D011346:Prochlorperazine; C084825:thioproperazine
CHLORPROMAZINE TOXICOLOGY; CHLORPROTHIXENE; EXTRAPYRAMIDAL TRACTS; FLUPHENAZINE; IMIPRAMINE; MEPAZINE; METHOTRIMEPRAZINE; MONOAMINE OXIDASE INHIBITORS; PARKINSONISM; PHENOTHIAZINES; PROCHLORPERAZINE; PROMAZINE; PSYCHOPHARMACOLOGY; RAUWOLFIA; SYMPATHOMIMETICS; THIOPROPERAZINE; THIORIDAZINE; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS; TRIFLUOPERAZINE
EXTRAPYRAMIDALE SYMPTOME BEI DER ANWENDUNG VON PSYCHOPHARMAKA.